Hair Growth Clinical study

A PROSPECTIVE, OPEN-LABEL, ONE ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE REMEDIST ADVANCE HAIR GROWTH TONIC IN IMPROVEMENT OF HAIR GROWTH IN HEALTHY MALE OR FEMALE VOLUNTEERS

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047817

Enrollment

Registered

2022-12-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: The Remedist Advance Hair Growth Tonic: Dosage form: Liquid, Usage: Spray on the affected area of scalp before 2 hours of bed timings and wash your head with lukewarm water in usual bat

Eligibility

Inclusion criteria

Inclusion criteria: 1.Willing to give informed consent. 2.Healthy male/female volunteers with mild to moderate hair fall aged between 18-55 years. 3.Must be able to adhere to the study visit schedule and other protocol requirements. 4.Willing to complete the questionnaires for the total duration of 45 days. 5.Willing to avoid usage of his/her own hair grooming products.

Exclusion criteria

Exclusion criteria: 1.Inability to provide voluntary consent. 2.Patients with pre existing severe systemic disease necessitating long term medication. 3.Subjects suffering from Trichotillomania a compulsive behaviour that necessitates pulling of hair. 4.Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation. 5.History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ necessitating chemotherapy. 6.Use of hair creams, hair shampoo and for one week prior to Baseline. 7.Multivitamins, iron supplements and folate are acceptable, but should be used consistently throughout the study. 8.Subjects who have had a hair head procedure (transplant) within 4 weeks before enrolment or during the study. 9.Subjects who abuse drugs or alcohol (drug screening not required). 10.Local (scalp) and systemic fungal infection 11.History of recurrent bacterial infection (at least 3 major infections resulting in hospitalization and/or requiring intravenous antibiotic treatment within the past 2 years) 12.Use of any investigational medication within 4 weeks prior to start of study.

Design outcomes

Primary

Measure	Time frame
â?¢ Visible difference in hair growth from baseline to last visit â?¢ % Reduction of hair fall from baseline to last visit. Timepoint: Day 0 to Day 45	—

Secondary

Measure	Time frame
To evaluate the consumer acceptance as well as their response towards the product through a feedback questionnaire. Timepoint: Day 0 to Day 45	—

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt. Ltd

ashok@radiantresearch.in9880999297

Outcome results